All articles by Shreosree Banerjee

NEBA Health announces validation results of FDA-approved brainwave-based test for ADHD

NEBA Health has announced validation results for the first US Food and Drug Administration (FDA) cleared biomarker, which can assist in the reduction of attention deficit hyperactivity disorder (ADHD) overdiagnosis.